[Lymphoma-current status of molecular targeting treatment and alternation in treatment strategy after the WHO classification change].
Shimane university hospital, Shimane, Japan.
Jyunji
J
Suzumiya
D000107:Acetylation / Q000187:drug effects; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D014944:World Health Organization
D000906:Antibodies; D000970:Antineoplastic Agents